Technology firm Quantum Foundry Copenhagen and the Novo Nordisk Foundation have announced plans to construct a 5,300 m² commercial quantum chip fabrication facility in Copenhagen, Denmark. Operational by 2027, the infrastructure is engineered to bridge academic research with industrial manufacturing, offering commercial wafer fabrication, characterization, assembly, and packaging services to global quantum technology vendors.
| [ Quantum Foundry Copenhagen Facility & Funding Overview ] | ||
|---|---|---|
| Facility Footprint & Schedule | Core Manufacturing Capabilities | Funding & Strategic Alignment |
| • 5,300 m² Specialized Cleanroom Facility | • Ultra-High Vacuum (UHV) Nanofabrication | • Novo Nordisk Foundation (DKK 2.9B / €390M Total) |
| • Target Opening: 2027 | • Atomic-Precision Quantum Materials Synthesis | • Aligned with EU Chips Act & Quantum Europe Strategy |
| • Location: Copenhagen, Denmark | • Wafer-Scale Assembly, Packaging & Testing | • Integrated with Niels Bohr Institute NQCP Target (2034) |
Ultra-High Vacuum Nanofabrication and Commercial Services
While European research centers maintain strong scientific outputs in quantum physics, scaling physical hardware requires dedicated commercial-grade semiconductor tooling and pure material growth capabilities. Quantum Foundry Copenhagen addresses these fabrication bottlenecks:
- Atomic-Precision UHV Processing: Utilizes Ultra-High Vacuum (UHV) growth and bottom-up engineering techniques to synthesize high-purity quantum materials, minimizing defect densities that cause decoherence in physical qubits.
- End-to-End Packaging and Assembly: Integrates nanofabrication cleanroom space with advanced material characterization, automated chip testing, and packaging lines to support scalable production of central processing units for quantum systems.
- Commercial Merchant-Foundry Model: Operates as an open commercial platform, providing contract wafer manufacturing to external quantum hardware startups, industrial partners, and research institutions across multiple qubit modalities.
Integration with NQCP and EU Sovereignty Mandates
The facility builds on the Novo Nordisk Foundation’s total commitment of DKK 2.9 billion (€390 million) to quantum technologies, working in tandem with the Novo Nordisk Foundation Quantum Computing Programme (NQCP) at the Niels Bohr Institute (University of Copenhagen), which targets building a fault-tolerant quantum computer before 2034.
The initiative aligns with the European Union’s broader strategic framework—including the EU Chips Act, the Quantum Europe Strategy, and the forthcoming European Quantum Act—aimed at establishing regional manufacturing capacity for critical semiconductor and quantum components.
Review the official release on Novo Nordisk Foundation here.
September 4, 2026
